SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is experiencing an intense sell-off and community debate following the abrupt departures of its CFO and general counsel amid an ongoing accounting review, delayed regulatory filings, and reduced financial guidance. While many see the over 50% plunge as an extreme overreaction and a potential buying opportunity, others express deep concern over financial irregularities, referencing a past short report, and caution against further downside.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending following its preliminary Q3 revenue exceeding expectations, sparking a surge of investor enthusiasm. The community is actively discussing the company's substantial year-over-year growth and its reinforced position as a crucial 'picks and shovels' provider for the expanding AI data center infrastructure.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is generating strong community buzz as its AI-powered ecosystem expands with new exchange listings and cross-chain integrations, leading many to anticipate significant price milestones and further utility growth.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Satellos Bioscience (MSLE) is trending following its recent NASDAQ listing and a significant $50 million financing, sparking intense debate around its novel Duchenne Muscular Dystrophy drug, SAT-3247. The community is split between those hailing its "revolutionary" muscle regeneration potential and acquisition prospects, and skeptics citing its early-stage data and concerns over dilution.

NexGen Energy Ltd. engages in the acquisition, exploration and development of uranium properties. Its uranium project portfolio includes Arrow, South Arrow, Harpoon, Bow, IsoEnergy, SW1, SW2, SW3, and IsoEnergy properties. The company was founded by Leigh B. Curyer on March 8, 2011 and is headquartered in Vancouver, Canada.

NexGen Energy Ltd

NexGen Energy (NXE) is trending following a critical short report from Culper Research that challenged its valuation and production capabilities, sparking a strong defense from the community. Investors are refuting the report's claims, underscoring the company's world-class uranium deposit and its strategic role in meeting rising global nuclear and AI-driven energy demand as it approaches key regulatory milestones.

Ferrari NV is a holding company, which engages in the design, engineering, production, and sale of luxury sports cars. The firm's models include the F12Berlinetta, 488GTB, 488 Spider, 458 Speciale, California T, the LaFerrari Hybrid, LaFerrari, and the FF four-wheel drive. It participates in car racing such as Formula One. The company was founded by Enzo Anselmo Ferrari in 1939 and is headquartered in Maranello, Italy.

Ferrari N.V.

Ferrari's recent stock plunge stems from conservative long-term growth guidance and a reduced electric vehicle target, sparking debate among investors. While some fear a slower EV transition and high valuation, others see an overreaction, emphasizing the brand's unmatched luxury demand, historically conservative guidance, and active share buyback program.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors react to the inauguration of its Eagle Line pilot production facility, signaling a crucial step towards scalable solid-state battery manufacturing. The community is actively debating whether this progress, including observed OEM presence, translates to imminent commercialization and new partnerships, or if skepticism over revenue and formal customer announcements will persist ahead of upcoming earnings.

Syntec Optics Holdings, Inc. engages in the design and manufacture of optics and photonics enabled products. The company was founded in 1981 and is headquartered in Rochester, NY.

Syntec Optics Holdings Inc. - Ordinary Shares - Class A

Syntec Optics Holdings Inc

Syntec Optics (OPTX) is gaining traction from new ballistic optics orders for U.S. military augmented reality systems and increasing demand for its space and AI data center optics. The community is actively debating its low float and significant growth potential from defense and AI tailwinds against concerns over its current valuation and cash position.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is trending after reporting strong earnings that exceeded profit expectations and showed significant revenue growth, alongside a new healthcare customer deal. The community is actively discussing its sharp recovery after a volatile period marked by a secondary offering and a major analyst downgrade, emphasizing its long-term potential in AI robotics and warehouse automation despite ongoing valuation concerns.

Upwork, Inc. is an online marketplace which engages in the provision of businesses to find, hire, and pay freelancers for short-term and longer-term projects. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company was founded by Odysseas Tsatalos and Efstratios Karamanlakis in December 2013 and is headquartered in Palo Alto, CA.

Upwork Inc

Upwork's shares are plummeting following an earnings report that, despite Q4 beats, delivered weaker Q1 guidance, intensifying community debate over AI's potential to disrupt or enhance the gig economy platform. Bulls, however, see the dramatic sell-off as an opportunity, citing the company's strategic AI initiatives and long-term profitability goals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26

Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 PR...

Caris Life Sciences (NASDAQ:CAI) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Caris Life Sciences from a "hold" rating to a "buy" rating in a report on Saturday...

Caris Life Sciences (NASDAQ:CAI) Trading Down 9.8% - Here's What Happened

Caris Life Sciences (NASDAQ:CAI) Trading Down 9.8% - What's Next...

Caris Life Sciences Shares Rise More Than 3% In Pre-market As Q4 Prel Revenue Surges 116%

(RTTNews) - Caris Life Sciences Inc. (CAI), an artificial intelligence TechBio company, Monday reported that its preliminary fourth quarter revenue and full year revenue have increased by 116 percent...

Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results

Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results PR Newswire IRVING, Texas, Jan...

Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect

Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect...

Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire IRVING, Texas, Jan...

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute PR Newswire IRVING, Texas, Dec...

Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need

Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need Caris Life Sciences Announces Collaboration with Genentech to...

Caris Life Sciences (NASDAQ:CAI) Insider Luke Thomas Power Sells 62,250 Shares

Caris Life Sciences, Inc. (NASDAQ:CAI - Get Free Report) insider Luke Thomas Power sold 62,250 shares of the company's stock in a transaction on Thursday, December 11th. The shares were sold at an...

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

Caris Life Sciences Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.03	--	--	N/A
Q3 '25	-$0.18	$0.08	145.67%	BEAT
Q2 '25	-$0.22	-$7.97	-3550.82%	MISSED

CAI
Caris Life Sciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest CAI News

CAICaris Life Sciences Inc.